NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Zhejiang Ausun Pharmaceutical Co. Ltd (SHG: 603229)
603229 Technical Analysis
5
As on 31st Jul 2025 603229 STOCK Price closed @ 11.61 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.26 & Strong Buy for SHORT-TERM with Stoploss of 10.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
603229STOCK Price
Open | 10.52 | Change | Price | % |
High | 11.61 | 1 Day | 1.06 | 10.05 |
Low | 10.40 | 1 Week | 2.11 | 22.21 |
Close | 11.61 | 1 Month | 3.00 | 34.84 |
Volume | 110202971 | 1 Year | 0.73 | 6.71 |
52 Week High 11.99 | 52 Week Low 6.59 |
SHG China Most Active Stocks
600010 | 2.69 | -7.88% |
601162 | 5.32 | 2.70% |
600705 | 3.47 | 0.29% |
600811 | 0.36 | -2.70% |
601669 | 6.83 | 0.44% |
600157 | 1.43 | -2.72% |
600221 | 1.48 | -3.90% |
601360 | 11.30 | 6.20% |
601288 | 6.30 | 1.12% |
600117 | 4.46 | 6.19% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
603229 Daily Charts |
603229 Intraday Charts |
Whats New @ Bazaartrend |
603229 Free Analysis |
|
603229 Important Levels Intraday
RESISTANCE | 13.94 |
RESISTANCE | 13.19 |
RESISTANCE | 12.73 |
RESISTANCE | 12.27 |
SUPPORT | 10.95 |
SUPPORT | 10.49 |
SUPPORT | 10.03 |
SUPPORT | 9.28 |
603229 Forecast August 2025
4th UP Forecast | 18.3 |
3rd UP Forecast | 16.15 |
2nd UP Forecast | 14.83 |
1st UP Forecast | 13.5 |
1st DOWN Forecast | 9.72 |
2nd DOWN Forecast | 8.39 |
3rd DOWN Forecast | 7.07 |
4th DOWN Forecast | 4.92 |
603229 Weekly Forecast
4th UP Forecast | 16.97 |
3rd UP Forecast | 15.25 |
2nd UP Forecast | 14.19 |
1st UP Forecast | 13.13 |
1st DOWN Forecast | 10.09 |
2nd DOWN Forecast | 9.03 |
3rd DOWN Forecast | 7.97 |
4th DOWN Forecast | 6.25 |
603229 Forecast2025
4th UP Forecast | 22.52 |
3rd UP Forecast | 19.02 |
2nd UP Forecast | 16.86 |
1st UP Forecast | 14.69 |
1st DOWN Forecast | 8.53 |
2nd DOWN Forecast | 6.36 |
3rd DOWN Forecast | 4.2 |
4th DOWN Forecast | 0.7 |
Zhejiang Ausun Pharmaceutical Co. Ltd ( SHG China Symbol : 603229 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
603229 Other Details
Segment | EQ | |
Market Capital | 7291019264.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
603229 Address
![]() |
603229 Latest News
603229 Business Profile
Zhejiang Ausun Pharmaceutical Co., Ltd. develops, produces, and sells specialty drug substances and pharmaceutical intermediates. The company offers prostaglandins and its intermediates; APIs; fluorine and antibacterial products; and intermediates. It also provides products for liver disease, respiratory system, and cardiovascular and cerebrovascular, as well as entecavir for the treatment of hepatitis B. In addition, the company is involved in the customized processing, and research and development business. Zhejiang Ausun Pharmaceutical Co., Ltd. was founded in 2010 is headquartered in Linhai, China. Address: No. 5, Donghai, Linhai, China, 317016
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service